Lu Han is the Co-founder and CEO of Imviva Biotech, a clinical-stage company pioneering allogeneic CAR-T cell therapies. With a background in private equity from Morgan Stanley and an MSc from LSE, he now leads the development of "off-the-shelf" treatments for autoimmune diseases and cancer, backed by top investors.
Outside of his executive role, Lu demonstrates a personal commitment to advancing medical research. He has participated in fundraising events like the ASH Foundations morning run, showing his support for progress in blood disease research, a field directly related to his companys work.
His company, formerly Bioheng Therapeutics, rebranded to Imviva Biotech to reflect its strategic global expansion.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.